SeedRound Media
Rushed for time? Here is the top 5 Seed investors for Health Care startups. Scroll down for more information on these investors or to view the rest of the investors.
Name | Website | Stages | Location | Socials |
|---|---|---|---|---|
Wellcome Trust | Early Stage Venture, Late Stage Venture, Private Equity, Seed | London, England, United Kingdom, Europe | ||
Nova Growth Capital | Early Stage Venture, Seed | Liverpool, Liverpool, United Kingdom, Europe | ||
Flyer One Ventures | Early Stage Venture, Seed, Venture | London, England, United Kingdom, Europe | ||
DigitalHealth.London Accelerator | Seed | London, England, United Kingdom, Europe | ||
Hikma Ventures | Early Stage Venture, Late Stage Venture, Seed | London, England, United Kingdom, Europe |
At SeedRound we track over 200,000 investors and over 1,000,000 people who hold key positions in these firms. We use this directory of investors to highlight top employees, LP’s and funding organisations we think deserve more appreciation than they are currently getting.
We’ve ranked the top Health Care Seed investors in United Kingdom. The companies, startups and institutions listed in this article are all exceptional companies, well worth a follow. We have included links to their websites, socials and CrunchBase (if you’re interested in their financials).
We selected the organisations listed in this article based on:
- Track record
- Executive leadership
- Market share
- Innovation
- ESG rating
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Top Health Care Investors & Funds (United Kingdom)
Wellcome Trust
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Stages: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Health Care, Medical, Non Profit
Follow:
Nova Growth Capital
Nova Growth Capital is an award-winning fund that invests in disruptive SEIS & EIS companies. Allowing investors to take advantage of a growth-focused and diversified investment portfolio. Its deal flow comes exclusively from its Cofoundery Nova, a venture builder that has seen 36.5% growth in its portfolio year on year for 12 years. Nova employs 100+ startup experts to actively source and grow their portfolio of tech enabled, disruptive SEIS & EIS companies. The fund is an opportunity to invest alongside Nova Cofoundery Limited (“Nova”) in their portfolio of early-stage companies. The Fund, therefore, seeks to benefit from co-investing with experienced partners. Investment Strategy: The Nova Growth Capital fund invests in ideas stage and early stage startups, without any capital investment from the founder. Nova’s programme will take the founder from an initial idea to discovering its market and building the product. Nova mentors, explores, validates & scales founders and their ideas. The Fund seeks to offer investors a diversified exposure of a minimum of ten investee companies each of which is engaged in solving industry problems with the use of a digital solution. It is envisaged that each subscription will be deployed across each investee company on a diversified basis, at the discretion of Nova Growth Capital Limited and Sapphire Capital Partners. Nova seeks to leverage appropriate technology to source and mentor potential founders. This gives Nova the capability to perform real “in-person” due diligence on their entrepreneurs before it co-invests, it allows Nova to understand and model the performance funnel and gives Nova control of deal flow. Nova typically sees over 25 opportunities per investment that are made. SEIS & EIS tax incentive: The companies the fund invest in are expected to be SEIS-EIS-qualifying, which makes Nova Cofoundery SEIS & EIS Fund SEIS-EIS suitable for qualifying clients who would potentially benefit from the following tax reliefs: – Up to 30% income tax relief (50% for SEIS) – Tax-free investment growth – Capital gains deferral (or 50% capital gains tax exemption for SEIS) – Inheritance tax relief – Loss relief We are proud that in the 12 years we have been building ventures through the Nova Cofoundery, we have invested in everything we have co-founded. Now private investors are able to invest alongside the Nova Group through our SEIS and EIS fund.
Stages: Early Stage Venture, Seed
Location: Liverpool, Liverpool, United Kingdom, Europe
Industries: Apps, EdTech, FinTech, Hardware, Health Care, Marketplace, Medical, Retail Technology, Software, Wellness
Follow:
Flyer One Ventures
Flyer One Ventures is an international early-stage venture capital firm focused on early-stage startups from CEE region. The fund invests in future-proof startups, founded by exceptional teams, and operating on global markets worth more than $10 billion. Flyer One Ventures funds startups in Mobile, Health Tech, EdTech, Fitness & Wellness, B2B SaaS, Gaming, FoodTech, and AI/ML industries and helps them scale on international markets. Founded by the co-founder of BetterMe and supported by Genesis Tech, Flyer One Ventures has deep expertise in Digital Marketing, Product, PR, Branding, and Recruiting. Along with the financial investment, Flyer One Ventures actively supports its portfolio companies, helping them optimize Digital Marketing campaigns, hire R&D staff, build user-friendly products, and fundraise Series A and Series B rounds. Flyer One Ventures’ ultimate goal is to support early-stage startups in the geographies with low access to early financing and help them become global leaders by mentorship and daily support.
Stages: Early Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Artificial Intelligence, B2B, Casual Games, Food Delivery, Gamification, Gaming, Health Care, Machine Learning, Venture Capital
Follow:
Hikma Ventures
HV will act as an instrument of strategic growth in broadening Hikma’s offerings; it will allow Hikma to tap into opportunities in the growing digital health space.HV will invest in companies where Hikma’s expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company.We will invest in companies at all stages of development, including start-ups, spinouts, and consortia investments.Our initial investment size is up to $5 million per round. HV will look at global opportunities but with a focus on the US and the Middle East & Africa (MEA). We seek to actively partner with the management teams of portfolio companies to realize the potential of their products and technologies.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: London, England, United Kingdom, Europe
Industries: Finance, Health Care, Health Diagnostics, Venture Capital
Follow:
dotforge
dotforge is an intensive 13 week mentor-supported accelerator programme. It fast tracks high-growth startups through smart investment capital and a bootcamp process that develops robust and globally-connected businesses. The programme is located in Sheffield and is open to early stage startup teams from the UK , EU and the rest of the world. The programme and mentor pool has been developed to attract and support startups building B2B, big data or cloud-based supply chain products and services.
Stages: Seed
Location: Manchester, Manchester, United Kingdom, Europe
Industries: Big Data, Health Care, Social Entrepreneurship
Follow:
NCL Technology Ventures
NCL is a specialist investment manager and advisory boutique that acts as a commercialisation engine for disruptive technology SMEs. NCL started in 2010 as Narec Capital, a joint venture with the UK’s National Renewable Energy Centre. Its primary purpose was to commercialise the IP that came through the centre of excellence, on behalf of UK Plc. NCL exploits the commercialisation stage funding gap by identifying truly high potential technologies and providing them with both the resource and institutional investment capital required to turn them into high performing SMEs. They are true venture managers with an inherent technology backbone. Guided by a highly experienced investment committee and leading scientific advisory board, NCL have deployed over $55M into the health sector, as a lead investor, over the last 3 years.
Stages: Early Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Finance, Financial Services, Health Care, Venture Capital
Follow:
Welsh Development Agency
Welsh Assembly Government is a governmental organization that represents the country of Wales. They also do investing.
Stages: Seed
Location: Cardiff, Cardiff, United Kingdom, Europe
Industries: Business Development, Business Intelligence, Government, GovTech, Health Care, Local
Follow:
Neo Kuma Ventures
Europe’s first venture capital firm to focus solely on investments into psychedelic healthcare companies. Ten investments already executed with more in the pipeline.
Stages: Convertible Note, Early Stage Venture, Late Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Financial Services, Health Care, Medical
Follow:
Sova VC
Sova VC is an international investor focused on backing and building ambitious and disruptive technology companies. Its initial fund, launched in January 2021, targets early-stage (Late Seed and Series A) companies, with a particular focus on B2B and B2B2C marketplaces and software platforms. Its Liquidity Fund, launched in January 2022, provides flexible solutions to the direct secondary market allowing early-stage shareholders and investors in high growth technology companies to realise early returns. Sova VC Marketplace Fund Early stage We typically invest at Late Seed and Series A stages, and our initial investment will commonly be in the range of €1.5-2 million, growing to as much as €4 million in a single portfolio company. Sova VC Liquidity Fund Late stage We typically invest between £1-7 million to acquire equity in growth stage companies where early shareholders – such as founders , CEOs, managers, business angels, employees and other early-stage investors – wish to obtain partial or full pre-exit liquidity.
Stages: Early Stage Venture, Late Stage Venture, Secondary Market, Seed
Location: London, England, United Kingdom, Europe
Industries: Financial Services, Health Care, Information Services, Information Technology, Internet, Marketplace, SaaS, Software
Follow:
Start Codon
Start Codon identifies the most disruptive and innovative life science start-ups worldwide, seed-funds them and leverages the exceptional resources of the Cambridge Cluster to de-risk and drive their success
Stages: Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Biotechnology, Health Care, Incubators, Life Science, Venture Capital
Follow:
Tyson & Blake
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society. We develop inspiring businesses that share our goals and our values. We create a positive impact and long-term value for our investors, the companies we invest in and the communities we live in.
Stages: Early Stage Venture, Private Equity, Seed
Location: London, England, United Kingdom, Europe
Industries: Business Development, Financial Services, Health Care, Internet, Media and Entertainment, Natural Resources
Follow:
Future Care Capital
In pursuance of its charitable mission, Future Care Capital (FCC) will use its resources to identify and support innovation through the launch of a dedicated Innovation Fund. The Innovation Fund aims to help address major healthcare needs, such as mental health, ageing and living with chronic medical conditions, by investing in innovative enterprises. It will also have an ethical investment policy that will drive its activities in compliance with the charity’s policies and aims. The Fund will invest in UK based, early-stage, high-tech, high-growth enterprises in the field of digital health (including machine learning and AI), assisted living, services and Class I medical devices.
Stages: Early Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Follow:
Wayra & Novartis Health Call
We scale start-ups. We are now looking for our next cohort of remarkable start-ups to join our new programme called The Health Hub, built together with our partner Novartis, one of the leading pharma companies in the world. Our focus is on how Health Tech can be used to drastically innovate long-term disease management.
Stages: Seed
Location: London, England, United Kingdom, Europe
Industries: Advice, Health Care, Medical, Pharmaceutical, Training
Follow:
